Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06258109 · ClinicalTrials.gov registry record
Risk of Recurrent CeAD After Pregnancy
A clinical trial of Pregnancy Complications and Cervical Artery Dissection, sponsored by University Hospital, Basel, Switzerland.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 12
- Study locations
NCT06258109: Recruiting study of Pregnancy Complications and Cervical Artery Dissection, sponsored by University Hospital, Basel, Switzerland.
NCT06258109 is a study of Pregnancy Complications and Cervical Artery Dissection that is actively recruiting participants, run by University Hospital, Basel, Switzerland. The registered enrollment target is 1,000 participants, below the 3,765-participant average among 39 other Pregnancy Complications trials with a reported enrollment target (73% lower). The trial reports 12 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06258109, a study of Pregnancy Complications and Cervical Artery Dissection, is actively recruiting participants, sponsored by University Hospital, Basel, Switzerland.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 12
- Study locations
Study Summary
Primary objective: To determine whether pregnancy increases the risk of recurrent CeAD and delayed stroke in women with prior CeAD based on long-term data. Methods: Multicentric, observational case-control study based on pooled individual patient data from several stroke centers. Primary endpoint: Primary composite outcome measure includes the following outcomes: (i) occurrence of recurrent CeAD, (ii) occurrence of ischemic or hemorrhagic stroke, (iii) death.
Primary Outcome
The composite outcome measure includes the following outcome measures during the follow-up: (i) occurence of recurrent cervical artery dissection (CeAD), (ii) occurrence of any ischemic stroke, (iii) occurrence of any hemorrhagic stroke, (iv) death.
Conditions Studied
Study Locations (12)
Other
- Stroke Unit Sanatorio Allende - Córdoba
- Helsinki University Central Hospital - Helsinki
- Charité Universitätsmedizin, Centrum für Schlaganfallforschung - Berlin
- Neurologische Klinik und Poliklinik, LMU Klinikum Campus Großhadern - Munich
- Hadassah-Hebrew University Medical Center - Jerusalem
- Neurology Clinic, University of Brescia - Brescia
- Stroke Clinic, National Institute of Neurology and Neurosurgery Manuel Velasco Suárez - Mexico City
- University Hospital Basel, Stroke Center - Basel
- University Hospital Zurich, Stroke Center - Zurich
Utah
- University of Utah - Salt Lake City
Virginia
- University of Virginia - Charlottesville
Tyrol
- Department of Neurology, Medical University of Innsbruck - Innsbruck
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2025-07-01 |
What NCT06258109 shows while recruiting
NCT06258109 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 3,765-participant average among 39 other Pregnancy Complications trials with a reported enrollment target (73% lower).
The record links to 2 conditions, with Pregnancy Complications appearing as the primary indexed condition, and to 0 interventions.
NCT06258109 lists 12 locations in 4 states (Other, Utah, Virginia).
Frequently Asked Questions
What is clinical trial NCT06258109 about?
NCT06258109 is a clinical study titled "Risk of Recurrent CeAD After Pregnancy". Primary objective: To determine whether pregnancy increases the risk of recurrent CeAD and delayed stroke in women with prior CeAD based on long-term data. Methods: Multicentric, observational case-control study based on pooled individual patient data from several stroke centers. Primary endpoint:...
What is the current status of trial NCT06258109?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2023-01-01. Estimated completion is 2025-07-01.
What conditions does trial NCT06258109 study?
This clinical trial studies the following conditions: Pregnancy Complications, Cervical Artery Dissection.
Who is sponsoring clinical trial NCT06258109?
This trial is sponsored by University Hospital, Basel, Switzerland, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06258109 being conducted?
This trial has 12 study locations across Utah, Virginia, Tyrol. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06258109's enrollment target sits among peer trials
1,000 8th of 39 higher than 32 of 39 other Pregnancy Complications trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
RECRUITING · Phase 2
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Treatment With Aspirin After Preeclampsia: TAP Trial
RECRUITING · Phase 4
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI